Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 NET 1 Genitourinary 1 Endocrine 1

Conditions

Neuroendocrine Tumors 169 Carcinoid Tumor 27 Carcinoma, Neuroendocrine 22 Neoplasms 16 Gastro-enteropancreatic neuroendocrine tumor 16 Adenoma, Islet Cell 15 Pancreatic Neoplasms 12 Neoplasm Metastasis 10 Pheochromocytoma 8 Paraganglioma 8 Sarcoma 7 Colorectal Neoplasms 7 Carcinoma 7 Neuroectodermal Tumors, Primitive 6 Neuroblastoma 6 Gastrointestinal Neoplasms 6 Vipoma 5 Somatostatinoma 5 Gastrinoma 5 Cholangiocarcinoma 5 Carcinoma, Islet Cell 5 Breast Neoplasms 5 Small Cell Lung Carcinoma 4 Serotonin Syndrome 4 Digestive System Neoplasms 4 Anus Neoplasms 4 Thyroid Neoplasms 3 Salivary Gland Neoplasms 3 Ovarian Neoplasms 3 Neoplasms by Site 3

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Frailty × NET × Clear all

NCT05554003 2024-11-18

MeTe

European Institute of Oncology

Phase 2 Recruiting

Frailty, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡